A London-based genetic testing company is expanding to the U.S. market with a genetic testing service and cloud-based online platform designed to help medical and health experts tailor fitness action plans for their patients.
The company’s platform is designed to help medical and health experts deliver rapid analysis of patients’ DNA, by combining the testing of thousands of genetic markers with a specialist review of the data. The genetic information—combined with user’s environmental factors such as age, weight, diet, and lifestyle—is designed to advise health and fitness professionals about treatments, diet and exercise plans that match their patients’ unique profiles, with the goals of reducing costs and improving lives.
Rightangled offers four tests: Heart DNA, Fitness DNA, Women Wellness, and Wellness Pro.
“When we released our initial product, the Heart DNA test, our first online order came from the US,” recalled Abdullah Sabyah, Co-founder and CEO of Rightangled, in a statement. “For us, that was a sign, and now the US is 20% of our monthly sales. This organic US growth has been taking place without a marketing campaign or local business development.”
“Our mission is to enable genetic analysis to become a regular activity inside medical practices, fitness and wellness centers in the UK and further in the US as well,” Sabyah added. “The aim is to help specialists deliver the right care to their clients by giving them an instruction manual for that unique individual.”
Rightangled will expand Stateside through a collaboration it is launching with the ABHI (Association of British HealthTech Industries) Innovation Hub, a partnership between the Association and Dell Medical School at The University of Texas in Austin. The value of the partnership was not disclosed.
“The Hub will support promising health technology innovation whilst looking to develop value-based healthcare for the benefit of patients in Texas, throughout the US and at home in the UK,” stated Philip Kennedy, Chair of the ABHI.
Rightangled has opened a new office at Dell Medical School as part of a UK/US innovation sharing partnership program, at a time where the company is expanding its’ services across the Atlantic. Rightangled has recently inked service agreements with regional healthcare providers in Texas, partnering with logistic suppliers, accredited labs and other partners in the US with whom they will be delivering their services to American consumers.
Rightangled, is registered with the UK’s Care Quality Commission (CQC) and was seed-funded in 2017 by the UK’s National Health Service (NHS) England.
“We have invested in Rightangled because its technology and service offerings align with our work for the NHS, supporting the establishment of a regional genomics medicine service that takes in all aspects of personalized medicine and prevention, as well as effective diagnosis,” said Tony Davis, Commercial Director for the West Midlands Academic Health Science Network, part of the NHS.
